Gsa Capital Partners LLP Nova Bay Pharmaceuticals, Inc. Call Options Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NBY
# of Institutions
1Shares Held
2.94KCall Options Held
0Put Options Held
0About NovaBay Pharmaceuticals, Inc.
- Ticker NBY
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,988,400
- Market Cap $46.1M
- Description
- NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...